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Abstract 
 A liquid chromatography tandem mass spectrometry (LC-MSMS) method was 
developed and validated to detect for the presence of zolpidem in human hair 
samples.  Zolpidem is a sedative hypnotic whose adverse effects make it a common drug 
found in drug facilitated crimes (DFC).  It is important to be able to detect and quantitate 
the drug after a long period of time due to the victim’s delayed reporting of the 
crime.  Hair’s long window of detection makes it a useful matrix for DFC 
investigations.  The linear range of the assay was targeted at 2 pg/mg to 1,000 pg/mg and 
experiments designed to test this range returned acceptable R2 values (> 0.985) in all 
cases.  The lower limit of linearity was established at 2 pg/mg.  Accuracy and precision 
of the assay were determined through replicate analysis of quality control samples.  Both 
intraday (n=3) and interday (n=15) accuracy and precision data were within acceptable 
limits, +/- 20% error and 15% RSD.  The matrix effect, recovery, and process efficiency 
were determined to be 15%, 70%, and 10%, respectively.  Additionally, the processed 
sample stability of quality control samples at room temperature and dilution integrity of 
spiked samples were found to be acceptable.  No significant carryover was seen between 
samples. This validated method was used to analyze authentic hair samples from donors 
with reported zolpidem drug use as well as cosmetically treated samples spiked with 
zolpidem. Results indicate possible interferences in the analysis of zolpidem in 
cosmetically treated hair, but not authentic, untreated hair. 
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1.  Introduction           
 Sleep-aids are commonly prescribed to help treat insomnia in the U.S.  These sleep-
aids have been reported to facilitate crimes such as sexual assault (DFSA).  Zolpidem 
(Ambien) is one of these prescribed sleep-aids.  Its fast-acting effects and short-duration 
make it an effective agent for drug-facilitated sexual assaults.  Since victims do not report 
the crime in a reasonable amount of time, hair becomes the most important and beneficial 
biological matrix.  Hair samples can be analyzed to test for the presence of these drugs 
after a period of time (months) have passed.  A confirmatory liquid chromatography 
tandem mass spectrometry (LC-MSMS) method has been developed and validated to detect 
the presence of zolpidem in human hair samples.     
 Insomnia is a medical condition diagnosed in 5-15% of the North American and 
United Kingdom population  (Gunja, 2013).  In the past, benzodiazepines have been used 
to treat insomnia.  Zolpidem (e.g. Ambien) has since replaced the use of benzodiazepines 
for treatment because they have pharmacodynamic and pharmacokinetic advantages such 
as a shorter duration of action and half-life.  Zolpidem also does not disrupt sleep patterns 
or cause residual effects.  There is a low risk of dependence and abuse (Gunja, 2013).  
Zolpidem’s effects are important when it comes to determining its use in drug facilitated 
crimes. 
 Zolpidem is an imidazopyridine, a non-benzodiazepine.  It exhibits sedative-
hypnotic effects used to treat insomnia.  A standard dosage, 10 mg for adults, is taken orally 
prior to bed to reduce the time for sleep on-set.  The on-set is seen within 15 minutes of 
ingestion and has a half-life of 2-3 hours (Gunja, 2013).  Once ingested, zolpidem is readily 
absorbed by the gastric intestinal tract (GI) and metabolized in the liver.  Cytochrome p450 
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(CYP), metabolizes zolpidem into its inactive metabolites methoxyzolpidem and zolpidem 
carboxylic acid (Gunja, 2013).  CYP enzymes are part of the liver microsomal drug-
metabolizing system which handles endogenous and exogenous compounds (e.g. drugs).  
Specifically, for zolpidem, the CYP3A4 polymorph enzyme is responsible for oxidizing 
the molecules so that they can be removed from the body.  The primary pathway for 
elimination is through renal excretion. 
 Similar to benzodiazepines, zolpidem binds to gamma-aminobutyric acid (GABA) 
type-A receptors and exhibits sedative and hypnotic effects (Gunja, 2013).  GABA is a 
major inhibitory neurotransmitter in the central nervous system.  It is a multi-component 
transmembrane protein complex with multiple ligand binding sites.  GABA-A is an 
ionotropic receptor, with a ligand-gated chloride ion channel going across the membrane.  
The complex contains multiple subunits including a (1), β (2), and γ.  The subunits are 
further divided into their own subunits (e.g. a1, a2, a3, and a5).  Zolpidem is a 
benzodiazepine BZ1 (ω1) receptor agonist (Rust et al., 2012).  Unlike benzodiazepines, 
zolpidem selectively binds to the a1 subunit of the GABA-A receptor (Has et al., 2016).  
The a1 subunit mediates sedation and amnesia as well as sleep regulation, while a2 and a3 
mediate anxiety (Gunja, 2013).  Once zolpidem binds to the GABA-A complex, it increases 
the binding of the GABA neurotransmitter, thus increasing the frequency of the opening of 
the chloride ion channel.  When the channel is open, an influx of chloride ions enters the 
cell causing membrane hyperpolarization.  This moves the postsynaptic potential away 
from the threshold, thus inhibiting propagation of an action potential, ultimately causing 
inhibition of the central nervous system.   
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 There are possible adverse effects including hallucination and amnesia.  Adverse 
effects are increased with the use of zolpidem in combination with serotoninergic and 
noradrenergic agents such as tricyclic antidepressants.  Poisonings results in sedation and 
coma.  Deaths are rare and tend to occur with polydrug overdoses (Gunja, 2013).   
 In recent reports, there have been an increase in the misuse of zolpidem especially 
with forensic cases, drug-facilitated crimes, and motor vehicle crashes (Gunja, 2013).  
Hypnotic drugs such as zolpidem are effective agents for drug-facilitated sexual assaults 
because they require a low dose, have a rapid on-set of action, and a short half-life (Rust 
et al., 2012).  As mentioned, zolpidem acts on the central nervous system causing 
symptoms of drowsiness.  This is commonly found as the means of sedation in drug 
facilitated sexual assault crimes. 
 A lot of the time, victims do not report the crime until well after the crime has taken 
place due to the sedative effects of the drug or their fear of reporting the crime.  Thus, in 
order to examine the victim for exposure of the drug, the matrix studied must have a long 
window of detection.  In comparison to oral fluid, urine, and blood matrices, hair has a 
longer window of detection of weeks to months.  Hair is collected close to the scalp, at the 
vertex posterior, where the hair growth rate is the most consistent (LeBeau et al., 2011).  
Head hair has a known growth rate of 1 cm per month; however, the rate may change based 
on various factors such as age, pregnancy, and hormones (LeBeau et al., 2011). With a 
known rate, this allows for hair segmental analysis to determine the pattern of drug use 
over a period of time (LeBeau et al., 2011).  A one-time use can be seen with a short drug 
band, while chronic use would show a longer band down the hair segment away from the 
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root.  In addition to having a broad detection window, hair testing has a lower risk of 
adulteration, and an easier, non-invasive collection procedure.   
 Hair growth occurs it cycles.  It begins at the follicle.  Here, during the anagen 
phase, cells divide, growing new hair and pushing the club hair out from the follicle.  Hair 
cells stop dividing, thus growth stops at the catagen phase.  During the catagen phase, the 
outer sheath of the hair attaches to the root forming the club hair.  Lastly, the telogen phase 
is when the hair follicle is at rest (LeBeau et al., 2011).  The hair shaft is tough, yet flexible, 
composed of elongated keratinized cells within a membrane complex.  The membrane 
complex is comprised of the cuticle, cortex, and medulla.  The cortex provides the stability 
and color composition.  Within the cortex, are melanocytes which produce melanin 
pigments within melanosomes (Pragst & Balikova, 2006).  The melanin is transferred to 
keratinocytes where they are able to absorb light and give the hair color.  Surrounding the 
cortex are overlaying shingle-like cells containing pigmentation to the matrix, the cuticle.   
The cuticle is also responsible for the chemical and physical resistance to the cell matrix 
(Pragst & Balikova, 2006).  In some hair, a medulla is present within the middle of the hair 
shaft (LeBeau et al., 2011).  Surrounding the outside of the hair follicle is a capillary system 
which provides nutrients to the growing hair as well as a means of drug incorporation. 
 Drugs can become incorporated into the hair through various pathways.  They can 
enter through passive diffusion through the skin, blood capillaries, or sweat (Pragst & 
Balikova, 2006).  Another way is through external exposure from the environment or others 
in the surrounding proximity.  Drugs are deposited into the growing hair structure by 
binding to proteins, melanin, or lipids of the membrane complex (Cui et al., 2013).  Melanin 
is the target of drug incorporation due to its ability to bind drugs.  Long polymer strands of 
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dopaquinones form melanin.  These polymers contain carboxyl groups (acidic 
characteristic) that are susceptible to donating a proton leaving a negative charge (Ghiani 
et al., 2008).  Positive charged ions have a greater affinity to melanin through electrostatic 
interactions.  The incorporation of basic drugs into hair has been seen (Kintz, 2007).  There 
have been some suggestions that the amount of melanin within the hair is related to the 
amount of drug that is incorporated.    Based on this understanding, it is believed that 
various hair colors, hair types, and cosmetic treatments will affect the drug’s incorporation.  
The pKa of the compounds and the pH of the matrix cells are important because they 
determine the degree of ionization of the acidic or basic compounds following protonation 
or deprotonation.        
 In order to prevent external contaminants from causing positive hair results, the hair 
undergoes extensive decontamination and washing procedures prior to analysis.  Since 
zolpidem is orally administered and not smoked, the metabolites do not need to be studied 
to determine if zolpidem was present due to external smoke contamination.  The 
decontamination and washing steps remove interferences from the surface of the hair 
matrix such as hair products, dye, shampoo, exogenous analytes, and sweat. 
 Presumptive screening tests can initially be used to test for the presence of the drug 
based on a cut-off concentration.  Enzyme-linked immunosorbent assay (ELISA) 
commercial kits are a common screening technique used.  Positive samples need to be 
further analyzed using a more specific chemical method in order to confirm its presence 
and concentration. 
 Instrumental analysis is more sensitive and requires samples to be cleaned prior to 
analysis.  Solid-phase extraction is used to free the drug from the hair matrix.  Cartridges 
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containing a solid stationary phase retain analytes using sorbent-analyte interactions.  
These interactions include hydrophobic, hydrophilic, and electrostatic based on the 
stationary phase and the analyte.  In order to activate the polymer bed, a solvent is used to 
condition it.  Samples are loaded into the cartridges allowing for drugs to bind through 
various mechanisms to the sorbent bed while unbound material is removed from the 
cartridges.  The cartridges are washed to remove excess material that is not bound to the 
cartridges.  Solvents are added in order to break the interactions holding the drugs to the 
stationary phase of the column, freeing the drugs for analysis (Supelco, 1998).  Solid-phase 
extraction not only frees drug from matrices, but they clean-up the sample prior to 
instrumental analysis.  
 Liquid chromatography tandem mass spectrometry (LC-MSMS) is the ideal 
technique for confirmation testing.  Liquid chromatography allows for various types of 
samples to be analyzed as opposed to gas chromatography where the sample has to be in 
the gaseous phase in order to be analyzed.  The separation from LC is performed at a high 
resolution.  A solid stationary phase retains the analyte to the column, while the liquid 
mobile phase pushes the analyte through the column.  Separation of the components is 
based on polarity between the solid and liquid phases.   Tandem mass spectrometry allows 
for the sensitive detection of trace amounts of drug.  An ionization source is used to remove 
the solvent from the sample and create small gas phase ions in a vacuum.  Electrospray 
ionization is a common ion source used prior to mass spectrometry.  In this source, the 
solvent and analyte compete for space inside of a droplet.  Positive charge builds up and 
blows apart to form small ions in an aerosol.  The ions are then attracted into the mass 
spectrometer through vacuum and magnetic fields.  Once inside, the ions travel to the first 
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mass analyzer and are separated by their mass-to-charge ratio.  Ions that meet the qualifying 
ratio are the “parent” ions.  The “parent” ions then move to the collision cell where they 
come into contact with N2 molecules and break apart to form “daughter” ions.  The 
“daughter” ions move to the final mass analyzer where they are separated based on their 
mass-to-charge ratio (Skoog et al., 2007).  Since multiple transitions (parent to daughter 
ions) are being monitored, the mode of the mass spectrometer is in multiple reaction mode 
(MRM).  A qualifier and quantifier transition are used to detect and then quantify the 
analyte present.  The combination of the liquid chromatography with mass spectrometry 
results in a rapid, specific, sensitive, and robust method for confirmatory testing. 
 Other studies for the detection of zolpidem in hair using LC-MSMS have been 
done.  In one study, Kim and authors used 10 mg of washed hair (a methanol and deionized 
water wash) followed by a methanol digestion at 38 ºC for 16 hours.  To extract the drug, 
the substrate was evaporated and the residue was reconstituted with methanol and mobile 
phase A and then filtered through a polyvinylidenefluoride (PVDF) microporous 
membrane prior to LC-MSMS injection (Kim et al., 2011).  Their LC-MSMS method had 
a linear working range of 0.25 – 5 ng.  For zolpidem, the LOD was 0.005 ng totoal and the 
LOQ was 0.25 ng total.  Matrix effect was an average of 88% and 90% for the LOD and 
LOQ, respectively.  Recovery was 93% and 89%, respectively.  Process efficiency was 
81% and 79%, respectively (Kim et al., 2011).  Based on the results, there is a significant 
matrix effect seen due to ion suppression.  Another hair analysis of zolpidem involved in 
drug facilitated crimes by Salamone and authors used 100 mg of hair, washed the hair 
(dichloromethane) and incubated the samples in methanol for 15 hours at 55 ºC.  The 
organic phase was collected, evaporated, and reconstituted with the mobile phase.  The 
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working linear range was 2 – 100 pg/mg, the matrix effect was -4.7% (compared the peak 
area of 25 pg/mg spiked into hair to the peak area of a methanolic standard at the same 
concentration) (Salomone et al., 2012).  
The goal of the present project was to develop and validate a sensitive and efficient 
LC-MSMS analysis for the quantitative detection of zolpidem in hair.  The established 
method would be validated using various standard procedures to ensure it is acceptable for 
clinical and forensic laboratory usage.  This LC-MSMS method can then be applied to 
solving various cases including drug facilitated crimes. 
2. Materials  
 2.1. Chemicals and Reagents. 
 Zolpidem (1.0 mg/mL in 1 mL methanol) (Z-017 Lot: FE04251603) and Sedative 
hypnotics internal standard, containing zolpidem-d6 (Lot: IS1603-17SED (1)) were 
purchased from Cerilliant (Texas, USA) and were stored in the fridge.  HPLC grade 
methanol, dichloromethane, and isopropanol were obtained.  Phosphate buffer, pH 6.0, 
pouches were from United Chemical Technologies (Bristol, PA).  Ammonium hydroxide 
reagent was from Spectrum Chemical Manufacturing Corporation.  Glacial acetic acid and 
sodium hydroxide pellets were from Sigma-Aldrich.  Hair extraction buffer (HEB) was 
purchased from Immunalysis (Pomona, CA).   
 2.2. Standard Solutions 
 Working standard solutions were prepared using the purchased certified stocks of 
zolpidem (at 1 mg/mL in methanol) and sedative hypnotics internal standard.  A working 
solution of internal standard at a concentration of 100 ng/mL was prepared in deionized 
water by the dilution of 10,000 ng/mL stock solution.  Zolpidem working standards were 
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prepared at concentrations of 100,000 ng/mL, 10,000 ng/mL, 1,000 ng/mL, 100 ng/mL, 10 
ng/mL, and 1 ng/mL in methanol by serial diluting the zolpidem 1 mg/mL standard stock 
solution. 
 2.3. Specimen 
 Negative hair including cosmetically treated samples were provided by Cordant 
Health Laboratory for drug analyses.  They were tested negative by using a LC-MSMS 
analytical method.  The samples were decontaminated as described later (section 3.1) to 
remove contamination that could interfere with the analyses.  Authentic donor hair samples 
with reported zolpidem drug use were obtained from the University of Pennsylvania for a 
matrix correlation project.  This project used anonymous, consented donor samples (oral 
fluid, urine, plasma, and hair, if applicable) to determine if there was a drug concentration 
correlation seen between the various sample matrices for a given drug. 
3. Methods 
3.1. Sample Decontamination 
 Hair samples were first decontaminated to remove contaminants such as dye, 
sebum, shampoo, and any other external interfering agents.  A clump of hair was placed 
into a beaker with dichloromethane covering the top of the hair.  The solution was swirled 
for 2 minutes, decanted, and dried under a light flow of nitrogen.  Isopropanol was added 
covering the hair, the solution was swirled for 2 minutes, and decanted.  Then methanol 
was added covering the hair, the solution was swirled for 2 minutes, decanted, and dried 
under a low flow of nitrogen.  The hair was stored in a folded piece of paper inside of an 
envelope and left in a drawer at room temperature until analysis. 
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3.2. Method Development: Hair Digestion 
 Fortification of the hair was performed to ensure that the hair would be positive for 
zolpidem when developing the LC-MSMS method.  A solution of dH2O: DMSO (1:1) was 
added to 5 g of decontaminated hair.  Zolpidem was spiked at 100 times the expected cut-
off (20 pg/mg).  In addition, to increase the total volume, 5 mL of 100,000 ng/mL, 1 mL 
of deionized water, and 1 mL of DMSO were added.  The hair was soaked and sonicated 
every 2-3 days.  After 5 days, the hair tested positive using a LC-MSMS method.  
 Hair extraction buffer (HEB) and 1M sodium hydroxide were both tested to 
determine which digestion solution recovered the most amount of drug.  Two sets of 
fortified hair samples were prepared (30 mg).  The samples were washed with 3 mL of 
methanol and twice with 3 mL of phosphate buffer (pH 6.0), each time vortexed, 
centrifuged, and decanted, except for the last wash with phosphate buffer.  The last wash 
was saved to determine the efficiency of the washing procedure.  In one set of samples, 1 
mL 1M sodium hydroxide was added, vortexed, and centrifuged.  The tubes were placed 
into a hot block for 30 minutes at 70 °C.  After, they were cooled to room temperature and 
180 µL of 20% acetic acid was added, vortexed, and centrifuged.  In the second set of 
samples, 1 mL of HEB was added to the tubes, vortexed, and centrifuged.  The tubes were 
then incubated for 2 hours at 75 °C.  After they were cooled to room temperature, 1 mL 
phosphate buffer (pH 6.0) was added, vortexed, and centrifuged.  Each set’s supernatant 
was removed, spiked with internal standard, extracted with the solid-phase extraction 
method, dried down with nitrogen, reconstituted with 0.1% formic acid, and injected into 




3.3. Hair Digestion and Cleanup     
 Decontaminated hair samples (30 mg) were cut into small pieces (~1 mm) and 
aliquoted into 12 x 75 mm tubes.  The samples were washed to ensure that all interferents 
were removed for a clean LC-MSMS anlysis.  The hair was washed with 3 mL of methanol 
(vortex and centrifuged for 5 min. at 4200 rpm) and decanted, and twice with 3 mL of 
phosphate buffer (pH 6.0) (vortex and centrifuged for 5 min. at 4200 rpm) and decanted.  
This cleans the hair from any external contamination that they might have come into 
contact with. The washed cut hair was then spiked to create a zolpidem working range (2 
pg/mg to 1,000 pg/mg) (Table 1).  A sedative hypnotic internal standard (60 µL of 100 
ng/mL) was also added to each sample. 















*Quality Control (QC) 
 For the digestion of the hair, a 1 mL aliquot of 1 M NaOH was added and the 
samples were vortex and centrifuged at 4200 rpm for 5 minutes.  The samples were 
incubated for 30 minutes at 70°C in a hot block.  Neutralization followed with 180 µL of 
20% acetic acid, vortex, and centrifuged at 4200 rpm for 5 minutes.  The supernatant was 









Negative Control 0 ---- ------- 
1 2 1 60 
2 5 10 15 
3* 10 10 30 
4 20 10 60 
5* 50 100 15 
6 100 100 30 
7* 200 100 60 
8 500 1000 15 
9 1000 1000 30 
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 Solid-phase extraction of the drug was performed using an automated liquid 
dispenser (ALD) and Strata-XC cation exchange cartridges.  The cartridges were 
conditioned with methanol and water, and then flashed with N2 gas for 19 seconds to lightly 
flush out the contents.  A LEUR seal was attached and 0.1 M phosphate buffer was added.  
The samples were then loaded and the LEUR seal was removed.  Next, the cartridges were 
washed by first flushing out the contents with N2 gas followed by the addition of water and 
25% methanol, and another flushing with N2 gas.  The cartridges were left to dry for 14 
minutes under a low nitrogen flow.  After drying, an elution solvent of dichloromethane: 
isopropanol: ammonium hydroxide (70:26:4) was added to the cartridges to allow the free 
drug to elute into autosampler vials.  The vials were then placed in a concentrator under a 
low nitrogen flow at 40°C for about 15 minutes until the vials were completely evaporated.  
Next, the vials were reconstituted with 50 µL of the mobile A phase: 1% formic acid and 
vortexed. The vials were then loaded onto the LC-MSMS for analysis. 
3.4. LC-MSMS Instrumental Analysis 
 The LC-MSMS confirmatory analysis was performed on an Agilent 1290 liquid 
chromatograph with 6460 triple quadrupole mass selective detector.  An LC-MSMS was 
used for confirmatory testing because it provides a high throughput and sensitive analysis.  
The Agilent instrument uses two columns simultaneously that are connected by a switch 
valve to avoid the use of post-column switching and the associated dead volume.  Also, the 
use of two columns working simultaneously allows for the analysis and re-equilibration of 
a second column.  This saves the time of switching and cleaning columns as well as 
increasing the throughput.  A Kinetex® 2.6 µm Biphenyl 100 Å Column; 50 x 2.1 mm 
reverse phase column was used.  The biphenyl column has strong pi-pi interactions and is 
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non-polar.  This is good for the retention of hydrophilic aromatic compounds (Kinetex 
Biphenyl, n.d.).  A set method “Sedative Hypnotic Hair” was optimized and used for 
analysis.  The following are the method’s parameters: 
 Injection: 20 µL 
Mobile Phase 
 Mobile Phase %A: Water 
 Mobile Phase %B: Methanol 
 Mobile Phase Composition: 






Temperature: 50 °C 
Triple Quadrupole MS Parameters 
Acquisition Mode: ESI (+ ion) 









0.00 30.00 0.700 
0.30 30.00 0.700 
1.20 60.00 0.700 
2.00 60.00 0.700 
2.01 30.00 0.700 











Zolpidem d6 √ 314.2 65.1 175 80 7 Positive 
Zolpidem  308.2 235.1 150 36 7 Positive 
Zolpidem  308.2 65.1 150 80 7 Positive 
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 ESI Source Parameters 
 Gas Temperature:  350 °C 
 Gas Flow: 10 L/min. 
 Nebulizer Pressure: 50 psi 
 Sheath Gas Temperature: 400 °C 
 Sheath Gas Flow: 11 L/min. 
 Capillary Voltage: 4000 V Positive 4000 V Negative 
3.5. Method Validation 
 Validation of the confirmatory method using LC-MSMS contains various 
procedures that have to be completed in order to validate that the developed method works 
prior to being used in the laboratory.  The analytical method was validated using spiked 
negative decontaminated hair and the following parameters were evaluated: accuracy and 
precision, linearity and sensitivity, matrix effect, recovery, and process efficiency, 
carryover, dilution, stability, selectivity, and proficiency testing. 
 First, accuracy and precision testing were performed by preparing and examining 
qualitative controls (10, 50, 200 pg/mg) in triplicates (intraday) and in triplicates for over 
five days (interday).  Accuracy (bias) compares the expected result with the measured 
result.  Systematic error can result in deviations between the two results. Precision 
measures the closeness of the samples performed in replicates.  If deviations are seen, 
random errors can be the cause.  The coefficient of variation (CV) is used to measure the 
accuracy and precision of the data.  Acceptable data for each analysis is a %CV <10. 
 Linearity and sensitivity were examined by preparing calibration curves once per 
day over the course of five days to evaluate their linear range.  The concentration of the 
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analyte in the matrix over the range of analyte concentrations being studied (the working 
range) has to be directly related to the response of the method in order for there to be 
linearity.  Thus, the working range has to be tested to ensure it is in linear range.  Validation 
was complete when all of the samples fell within 15% of their expected values and the 
curve r2 values were above 0.985.   
 Matrix effect was examined next to determine the %recovery, the interference of 
the hair matrix, and the process efficiency of the extraction technique.  Three groups were 
created at the same midway concentration (100 pg/mg) with no internal standard added: 
neat un-extracted (Group A), post-extraction standards (Group B), and pre-extraction 
standards (Group C).  Group A consisted of three neat un-extracted standards, Group B 
consisted of prepared and extracted samples in triplicates for five different sources, and 
Group C consisted of prepared samples in triplicates for five different sources.  Matrix 
effect involves the alteration or interference of an unintended analyte or substances in the 
sample matrix which changes the response of the LC-MSMS instrument.  The intended 
analyte in the sample matrix has to be tested to ensure there is no interference.  This is done 
by examining the recovery, process efficiency, and ultimately the matrix effect.  Once there 
is high recovery and process efficiency and a low matrix effect, the data can be accepted. 
 The efficiency of the LC-MSMS method was looked at next by determining 
whether or not there was sufficient carryover taking place.  High concentrations of sample 
remaining in the column and eluting with a lower concentration can cause problems when 
analyzing the data.  In order to determine if this is occurring and to determine how much 
is being carried over, two samples containing the upper limit of linearity (ULOL) and 10 
times the ULOL were prepared (1,000 pg/mg and 10,000 pg/mg respectively) as well as 
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two negative controls.  The ULOL and the 10x ULOL samples were injected into the LC-
MSMS.  Following each, a negative control was injected.  If there is a significant amount 
of carryover, the LC-MSMS method would be adjusted to correct it. 
 The stability of the samples at room temperature were examined next over three 
days.  A set of QCs was prepared (doubled everything throughout the experiment to ensure 
that there was enough sample to examine over three days).  The extraction and instrumental 
analysis of the samples were performed for the first day.  The remaining sample aliquot 
was then left out at room temperature to be injected for a second day and then repeated for 
a third day.  Stability testing is performed to show that the samples are stable throughout 
the procedure as well as during storage, if left at room temperature prior to analysis.  
Comparing freshly made samples with those that have sat out over time can demonstrate 
its stability. 
 Dilution testing is to ensure that the quantities that are being analyzed are accurate 
if a dilution is necessary if the concentration goes beyond the linear working range or less 
sample is available.  The ULOL was prepared at dilution factors (DF) of 2, 4, and 10, by 
diluting with the 1M NaOH solution.  Dilutions were added prior to digestion.  All values 
are accepted if their quantities, with dilution factors, are within +/- 15% of the expected 
values. 
 Selectivity study is done to test the method’s ability to select for only the 
compounds of interest and not the interferences in the matrix, standards, internal standard, 
or other analytes that might be present in the sample.  This study uses negative hair samples 
from different sources.  Three replicates of each source are prepared without standard or 
internal standard to test for the presence of any compound within the matrix itself.  This 
 17 
will ensure that the hair is purely negative.  Next, three replicates of each hair source are 
prepared with only internal standard at the concentration used in the calibration curve (60 
µL of 100 ng/mL).  This was to see if there was a standard response present from internal 
standard impurities.  Lastly, each of the five sources of hair were washed.  In five separate 
tubes, one at a time, 1 mL of 10,000 pg/mg of five different analytes (benzoylecgonine, 
oxazepam, hydrocodone, imipramine, and lorazepam) were added and dried down with N2.  
After all of the analytes were dried down, the tube residues were reconstituted with 1 mL 
of 2 pg/mg of zolpidem calibrator and spiked with internal standard.  The reconstituted 
solutions were added to the source samples.  The samples were then digested with 1 mL of 
1M NaOH, neutralized, and extracted.  The analytes were chosen from the College of 
American Pathologists’ “Master List” of common drug facilitated compounds.  The data 
was analyzed to see if the LOQ properly quantitates in the presence of other compounds. 
 Proficiency testing is performed using samples prepared by a Research and 
Development staff member.  Hair samples are spiked with a known concentration of 
zolpidem by a reputable source.  The concentration is unbeknownst to the scientist who 
will then test and analyze the sample.  Extraction and proficiency testing is implemented 
in order to test the method as well as the scientist, to ensure that they are working properly.  
The scientist’s quantitative results are then compared to the known reputable results to 
determine the efficiency of the method and the scientist. 
 Authentic, reported zolpidem positive, hair samples were obtained from the 
University of Pennsylvania in collaboration of a biological matrix correlation experiment.  
A study between Cordant Health Solutions and University of Pennsylvania is being 
conducted to quantify urine, oral fluid, plasma, as well as hair samples for a wide range of 
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drugs and correlate the concentrations within the four matrices.  These samples were 
obtained from anonymous donors who also reported their medical history for the study.  
The samples did not contain any markers that would identify the donor.  An aliquot of the 
positive zolpidem hair samples was analyzed using the LC-MSMS method developed.  The 
zolpidem hair concentrations were compared to the other matrices zolpidem 
concentrations. 
4. Ethics 
 Since this method development research involves human subjects, informed 
consent, information regarding the research, and additional protections will be required 
from the subjects.  Cordant Health Solutions, where this research is being performed, 
typically request positive samples from other drug testing labs as their human subject 
samples for validation work.  All of the samples are de-identified and lack any protected 
health information (PHI) in accordance with the Health Insurance Portability and 
Accountability Act (HIPAA) privacy rule.  The research being conducted is in an 
acceptable manner, applied towards the planning, execution, and reporting.  It is being 
performed ethically to protect the interest of the individuals involved and followed all 
federal, professional, and institutional guidelines and regulations. 
5. Results 
5.1. Method Validation 
 The developed LC-MSMS method produced a good separation and detection of the 
zolpidem analyte over the calibration range (2 to 1,000 pg/mg).  The zolpidem and its 






Figure 1. Zolpidem (left) and its deuterated form (right). 
 A representative chromatogram of zolpidem with internal standard in hair is 
shown in Figure 2.  The peak of zolpidem is shown to elute at 1.3 ± 0.2 minutes.  The 
parent ion of zolpidem has a mass-to-charge ratio of 308.2 m/z and two product ions of 
















Figure 3. LC-MSMS representative spectrum showing zolpidem ion fragments  
(m/z 308.2 à 235.1) and (m/z 308.2 à 65.1). 
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 A comparison between a 1M sodium hydroxide and hair extraction buffer (HEB) 
digestion was performed with the fortified hair to determine which had a higher drug 
recovery.  The last wash was also saved to see how well the washing procedure worked.  
The wash consisted of a methanol and phosphate buffer wash.  Table 2 shows the results 
of the washing procedure as well as the difference in recovery after both digestion methods.  
Zolpidem was recovered, after a 1M NaOH digestion, at a concentration five times great 
than that of an HEB digestion.  The low concentration of zolpidem seen in the last wash 
indicates a good washing efficiency.  Figure 4 depicts the comparison between the two 
digestion methods and the efficiency of the last wash.   
Table 2. Wash Efficiency and Recovery After Digestion (1M NaOH vs HEB) 
Sample Digestion Solution Concentration (pg/mg) 
1 – LW NaOH 14 
2 – LW NaOH 13 
3 – LW NaOH 14 
1 – H NaOH 5063 
2 – H NaOH 5137 
3 – H NaOH 8269 
1 – LW HEB 12 
2 – LW HEB 14 
3 – LW HEB 12 
1 – H HEB 1164 
2 – H HEB 1148 
3 – H HEB 1020 
*LW- last wash, H- hair 
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Figure 4. Washing efficiency and extraction recovery of zolpidem after a 1M NaOH and 
HEB digestion.  
 
 Since the 1M sodium hydroxide had a higher recovery, it was used as the digestion 
solution for the LC-MSMS analysis.  The recovered concentration post-digestion shows 
how well the fortification procedure worked in incorporating the drug into the hair as well 
as how well the recovery of the drug from the digested matrix worked. 
 Validation of the developed assay was tested using decontaminated negative hair 
(30 mg) samples and performing various validation procedures.  The hair was validated 
over a concentration range of 2 to 1,000 pg/mg.  The calibration curves were prepared 
using either quadratic or linear formulas to produce a best fit line with good r2 values.  
Good linearity was obtained when the r2 was greater than 0.985 (Table 3).  This was seen 





































Washing  Procedure  and  Extraction  Recovery  After  a  NaOH  v  
HEB  Digestion
NaOH  LW NaOH  Hair HEB  LW HEB  Hair
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Table 3. Linearity of Calibration Curves. 
Day Calibration Curve Formula R
2 
 
1 y = -0.003111x2 + 0.459669x – 0.002492 0.9854 
2 y = -0.009311x2 + 0.726733x – 0.002477 0.986 
3 y = -0.002977x2 + 0.230380 + 0.011476 0.9973 
4 y = 0.002845x2 + 0.250983x + 0.003026 0.9959 
5 y = -0.002611x2 + 0.586466x + 0.013747 0.995 
R2 values are weighted: 1/x^2 
 The intraday (n = 3) and interday (n = 15) precision and accuracy (bias) results for 
zolpidem at the quality control concentrations (10, 50, and 200 pg/mg) are seen in Table 4.   
The accuracy and precision data were within acceptable limits, +/- 20% error and 15% 
RSD.  The intraday precision and accuracy of the 10 pg/mg, 50 pg/mg, and 200 pg/mg QCs 
were 4% and 10%, 9% and -1%, and 2% and 2%, respectively.  The interday precision and 
accuracy of the 10 pg/mg, 50 pg/mg, and 200 pg/mg QCs were 9% and 2%, 9% and 4%, 
and 11% and 6%, respectively. 
Table 4. Intraday and Interday Precision and Accuracy of Zolpidem in Quality Control Hair 
Samples. 
Statistical Variable Concentration (pg/mL) 10 50 200 
Intraday (n = 3)*    
     Mean 11.0344   49.6598   203.7433  
     Precision (%RSD) 4.1165   9.3734   2.1176  
     Bias (%RE) 10.3437   -­‐0.6805   1.8716  
Interday (n = 15)**    
     Mean 10.186   51.998   212.608  
     Precision (%RSD) 8.640   8.889   11.418  
     Bias (%RE) 1.863   3.996   6.3039  
*Intraday results from Day 3 
**Interday results are the average of the 15 samples over 5 days 
Precision (%RSD) = ([mean]/ SD) *100 
Bias (%RE) = ([mean calculated] – [expected])/ ([expected]) *100 
 
 The matrix effect, extraction recovery, and process efficiency were performed 
twice since the results were not expected (Table 5).  The matrix effect for the five sources 
was observed to be on average 15% over the two days.  The extraction recovery and process 
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efficiency of the method for five sample sources averaged 70% and 10%, respectively over 
the two days. 
Table 5. Matrix Effect, Extraction Recovery, and Process Efficiency (100 pg/mg). 
Source 
(Color) 

















1 (N/A) 19 55 10 23 56 13 
2 
(Black) 10 63 6 16 86 13 
3 (N/A) 13 68 9 10 83 8 
4 
(Blonde) 17 73 13 16 81 13 
5 (Light 
Brown) 13 97 12 14 57 8 
Average 15 70 10 16 71 11 
%Matrix Effect = (Post-Addition/ Neat) *100 
%Recovery = (Pre-Addition/ Post-Addition) *100 
%Process Efficiency = (Post-Addition/ Neat) * 100 
 The process sample stability of zolpidem in hair was stable over five days at room 
temperature after the analysis of three samples at quality control concentrations (10, 50, 
and 200 pg/mg).  Figure 5 shows the stability of the QCs over five days.  Analysis of the 
samples was on Day 1.  The samples were then left out at room temperature and re-analyzed 
on Days 2 and 5.   
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Figure 5. Stability of QCs 10, 50, and 200 pg/mg over five days.  Samples were analyzed 
on Days 1, 2, and 5. 
  
 The dilution integrity showed accurate results between the expected and actual 
concentrations (Table 6).  The measurements of the diluted samples were within +/- 15% 
of the theoretical concentration. 









ULOL N/A 1000 1035 -3.5 
DF 2 1:1 500 525 -5 
DF 4 1:3 250 264 -5.6 
DF 10 1:9 100 108 -8 
  
 Carryover is analyzed to ensure that there is not leftover analyte in the analytical 
instrument after analysis.  The carryover was evaluated by analyzing two blank samples 
followed by high concentrations (1,000 and 10,000 pg/mg).  The two blank samples 





























carryover results for the ULOL, 10x ULOL, and the negative controls between analyses.  
Figure 6 shows the blank chromatograms after the ULOL and 10x the ULOL.  There was 
not a qualifier ion detected and only noise peaks were visible. 
Table 7.  Carryover results of the LC-MSMS. 




ULOL 3124205 1099794 
Blank 1 3858.98 1022388 
ULOLx10 4.5E+07 534712 


















       A      B 
Figure 6.  Blank sample chromatograms after the ULOL (A) and after 10x ULOL (B) 
showing noise peaks and no qualifier detected. 
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 The selectivity study showed that the hair matrix alone did not contain any 
endogenous and exogenous matrix interferences.  The potential of endogenous matrix 
interferences was assessed using five blank hair samples fortified with internal standard 
previous to this experiment.  Exogenous matrix interferences were assessed by the analysis 
of five blank hair samples fortified with five common drugs used to facilitate crimes at 
10,000 pg/mg, as well as 2 pg/mg of zolpidem (LOD).  The five drugs that were tested 
were benzoylecgonine, oxazepam, hydrocodone, imipramine, and lorazepam.  The 
analytical method was able to measure and differentiate the zolpidem analyte and internal 
standard in the presence of the five other compounds at high concentrations within the hair 
samples.  Table 8 shows the analyte and internal standard response, as well as the detected 
zolpidem concentration after the analysis of the five samples.  The 2 pg/mg zolpidem were 
detectable in samples 1-3, not in samples 4 and 5.  The method was selective to those two 
samples since the analyte was not detected less than the LOD.  Figure 7 depicts the 
chromatograms of the five samples for the zolpidem analyte m/z (308.2 à 235.1) and 
internal standard (m/z 314.2 à 65.1). 
Table 8. Selectivity Study of Five Hair Samples with Five Other Compounds. 








Zolpidem (2 pg/mg), 
Internal Standard, and 
Five Other Compounds 
1 57700 1269040 2.3736 
2 41195 1129552 1.6104 
3 72511 1459572 2.7309 
4 (dyed red 
hair) 
28308 1309256 0.3509 
5 (dyed red 
hair) 
15364 850157 0.0498 



















            4     5 
Figure 7. Chromatograms showing the zolpidem peak for samples 1-5. 
 
 The proficiency testing of spiked hair samples prepared by a research scientist at 
Cordant Health, were consistent with the expected results (Table 9).  The results were +/- 
15% of the actual concentrations. 
Table 9. Proficiency Testing. 
PT # PT Actual (pg/mg) 
PT Results 
(pg/mg) % Accuracy 
1 7.5 6.0147 -19.80 
2 25 23.9360 -4.26 
3 75 76.8704 2.49 
4 250 247.8854 -0.85 






5.2. Clinical Application 
 Authentic hair samples, positive for zolpidem, were obtained from the University 
of Pennsylvania.  The samples were analyzed using the developed method in collaboration 
with their on-going biological matrix correlation study.  The study used anonymous donor 
patients’ urine, oral fluid, plasma, and hair samples.  The patients’ medical history was 
noted.  Samples 022 and 210 were weighed (30 mg and 15 mg (DF 2), respectively) and 
internal standard was added.  The method’s digestion, extraction, and LC-MSMS 
procedures were performed.  Zolpidem was detected in samples 022 and 210 at 
concentrations of 578 pg/mg and 834 pg/mg, respectively (Table 10).  The correlation 
between the biological matrices is seen in Table 11. 
Table 10. University of Pennsylvania Correlation Study: Hair Analysis 
Sample Zolpidem Qualifier Zolpidem-d6 
SID Dil. RT Response Calculated Concentration 
Final 
Concentration RT Response 
022 1 0.994 10139665 577.9367 577.9367 0.981 1570265 
210 2 0.994 10147782 417.2332 834.4664 0.984 2172406 
 
Table 11. University of Pennsylvania Biological Sample Correlation for Zolpidem. 








022 65.6668 2.3989 56.9612 577.9367 




6. Discussion and Conclusion 
 The LC-MSMS method developed to detect the presence of zolpidem, a sedative-
hypnotic, in hair samples has been efficiently validated.  The zolpidem was seen to elute 
within approximately 1.3 minutes, with a total run time of 2 minutes. 
 A wash using methanol and phosphate buffer has shown to successfully remove 
external contamination on the surface of the hair.  The last wash that was analyzed from 
the fortified samples, showed low levels of drug compared to the amount of recovered 
drug.  The wash though, was not tested on interferences including dye, bleach, and other 
common cosmetic chemicals.  The influence of cosmetic treatments of hair on drug testing 
has been of concern for drug analysis in hair.  Products that are strong bases are expected 
to cause damage to hair (Jurado et al., 1997).  More specifically, damage to melanin within 
the hair follicle.  Thus, drugs may be lost from the matrix. 
 The digestion, using sodium hydroxide was seen to show a better drug extraction 
than hair extraction buffer.  Other digestion methods can possibly be tested that do not 
require a neutralization step such as methanol or an enzyme extraction.  The neutralization 
step, can be difficult since there can be variability with pH between sources causing the 
amount of neutralization solution to vary.  The solid-phase extraction using Strata exchange 
columns and the method used has shown to extract the zolpidem, basic drug efficiently. 
 The linearity, intraday and interday precision and accuracy, carryover, process 
sample stability, dilution integrity, and proficiency testing parameters yielded satisfactory 
results for the detection of zolpidem.  Matrix effect and selectivity showed results that were 
not expected but are accepted since they have known causes that can be investigated. 
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 Matrix effect was seen throughout all of the hair samples.  As a result of matrix 
effect, process efficiency was expected to be low due to 85% ion suppression.  Ion 
suppression is a form of matrix effect that is seen with liquid chromatography-mass 
spectrometry.  Modifying the instrumental component parameters and sample preparation 
can be considered to reduce or possibly eliminate ion suppression.  A cleaner extraction 
technique can be further investigated.  This method is subject to significant matrix effects, 
but with the exception of dyed hair samples, the method is sensitive enough to quantitate 
2 pg/mg in hair samples.    
 In the selectivity procedure, it was difficult to detect the LOD in samples 4 and 5.  
This may be due to these samples being cosmetically treated with dye.  Cosmetic treatments 
interfere with the melanin structure, thus altering the incorporation of drugs into the hair 
matrix.  There was limited authentic samples available for this research.  Some of the 
samples available were cosmetically treated. Future studies are required to determine the 
effect cosmetically treated hair has on drug analysis.  
 The hair samples in the University of Pennsylvania correlation study were found to 
have higher zolpidem concentrations than that in the other three matrices.  There does not 
appear to be a correlation trend between zolpidem within the various biological matrix 
samples. 
 Overall, this developed and validated confirmatory LC-MSMS method, compared 
to previous methods, is more sensitive with an LOQ of 2 pg/mg, quicker with a digestion 
of 30 minutes, and easier with a fast and automated extraction procedure (Salomone et al., 
2012) (Kim et al., 2011).  This method is useful for the quantitative detection of zolpidem 
in hair samples. 
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 The method developed was to detect the presence of zolpidem in hair samples.  A 
dosage study and segmental analysis was not performed.  A control study is needed to 
analyze hair samples after a single, low-dosage of zolpidem.  This will determine if the 
LOQ that was established in this method is acceptable for the low, single-dosage of 
zolpidem for a facilitated crime. 
7. Future Research 
 A future development of an ELISA screening technique would allow for an easy 
initial detection of zolpidem within hair samples.  The zolpidem commercial plates that are 
already available are not compatible with complex matrices such as hair samples.  As a 
result, various sample sizes, digestion methods, and solution volumes have to be studied.  
Also, a phosphate buffered saline wash might help to remove the non-specific binding, thus 
lowering the possible presence of interferences and increasing the absorbance.  
 The effects of various cleaning agents (e.g. shampoo, conditioner) as well as 
chemical and physical agents (e.g. dye, bleach, heat) should be studied.  Two samples that 
were analyzed in this experiment were red-dyed hair.  The dye might have altered the 
melanin structure within the hair, thus affecting the ability to detect the low levels of drug.  
Cosmetically treated samples should be analyzed as to how to better wash and extract low 
levels of analytes.  There have been previous studies showing the effects of cosmetic 
treatments on drug analysis.  Jurado and authors (1997) did a study showing that the 
chemical composition of various cosmetic treatments, including bleaching and dyeing hair, 
have an effect on drug stability.  They showed that strong basic treatments involving 
ammonium hydroxide and hydrogen peroxide (H2O2), affect the hair fiber causing 
alterations to the cuticle.  “Ammonium hydroxide opens the scales of the cuticle to facilitate 
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the entry of the other compounds, H2O2, a powerful oxidant, attacks the hair pigment and 
decolorizes the hair” (Jurado et al., 1997, p. 161).  Overall, the drug concentration in hair 
had decreased with the use of cosmetic hair treatments.  
 A segmental analysis of hair can be performed on hair samples when the root end 
is clearly noted.  Recent and long-term drug exposure can be determined through segmental 
analysis.  With the known rate of hair growth in head hair (1 cm/month), the identification 
and quantification of drugs and its metabolites along the length of the hair shaft can be 
determined for drug history.  Small segments of hair can be cut into known lengths and 
analyzed for drug exposure.
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